XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities    
Net (loss) income $ (59,910) $ 3,088
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 3,027 1,291
Provision for unrecoverable advances 27,642 10,933
Changes in fair value of derivative assets on loans to stockholders 5,572 (24,042)
Changes in fair value of warrant liabllities (13,484) 2,866
Changes in fair value of earnout liabilities (9,634)  
Gain on extinguishment of liability (4,290)  
Stock-based compensation 26,048 2,786
Non-cash interest 770 (137)
Non-cash lease expense (46) 63
Changes in fair value of marketable securities 25 0
Changes in operating assets and liabilities:    
Member advances, service revenue (3,526) (949)
Prepaid income taxes 665 746
Prepaid expenses and other current assets (7,013) (329)
Accounts payable 9,928 1,290
Accrued expenses (1,870) 3,573
Legal settlement accrual (197) 0
Other current liabilities (338) (2,044)
Other non-current liabilities 3 (23)
Interest payable, covertible notes 0 6
Net cash (used in) operating activities (26,628) (882)
Investing activities    
Payments for internally developed software costs (4,439) (2,267)
Purchase of property and equipment (305) (23)
Net disbursements and collections of Member advances (51,189) (15,196)
Purchase of short-term investments (196,777) 0
Purchase of marketable securities (302,382) (3)
Sale of marketable securities 274,500 3,915
Net cash (used in) investing activities (280,592) (13,574)
Financing activities    
Repayment on line of credit 0 (3,910)
Proceeds from PIPE offering 195,000 0
Proceeds from escrow account, net of redemptions 29,688 0
Payment of issuance costs (23,005) (2,007)
Proceeds from issuance of common stock for stock option exercises 1,574 910
Repurchase of common stock (1,583)  
Proceeds from borrowings on convertible debt 100,000 0
Proceeds from borrowings on debt and credit facilities 0 23,000
Net cash provided by financing activities 301,674 17,993
Net (decrease) increase in cash and cash equivalents and restricted cash (5,546) 3,537
Cash and cash equivalents and restricted cash, beginning of the period 32,372 5,069
Cash and cash equivalents and restricted cash, end of the period 26,826 8,606
Supplemental disclosure of non-cash investing and financing activities:    
Operating lease right of use assets recognized   2,514
Operating lease liabilities recognized   2,514
Property and equipment purchases in accounts payable 39 10
Conversion of convertible preferred stock to Class A common stock in connection with the reverse recapitalization 72,173 0
Recapitalization transaction costs liability incurred 7,500 0
Conversion of convertible notes and accrued interest to Class A common stock in connection with the reverse recapitalization 720 0
Conversion of B-1 Warrants to Class A common stock in connection with the reverse recapitalization 3,365 0
Discharge of PIPE promissory note in connection with the reverse recapitalization 15,000 0
Supplemental disclosure of cash (received) paid for:    
Income taxes (644) (721)
Interest 2,332 763
The following table provides a reconciliation of cash and cash equivalents, and restricted cash reported within the condensed consolidated balance sheet with the same as shown in the condensed consolidated statement of cash flows    
Cash and cash equivalents 26,379 8,243
Restricted cash 447 363
Total cash, cash equivalents, and restricted cash, end of period $ 26,826 $ 8,606